Market Value641,735,000
Total Holdings51
File Date2018-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VCEL / Vericel Corporation
SLGL / Sol-Gel Technologies Ltd.
GWP / GW Pharmaceuticals plc
IDRA / Idera Pharmaceuticals, Inc.
PRTK / Paratek Pharmaceuticals Inc.
NUVA / Nuvasive Inc
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
NTUS / Natus Medical Inc
PCRX / Pacira BioSciences, Inc.
MDWD / MediWound Ltd.
ANGO / AngioDynamics, Inc.
71426VAK4 / Pernix Therapeutics Holdings, Inc. Convertible Debt 4.25%
AGRX / Agile Therapeutics, Inc.
IVTY / Invuity, Inc.
BAX / Baxter International Inc.
VSCI /
VCYT / Veracyte, Inc.
GKOS / Glaukos Corporation
ATRS / Antares Pharma Inc
TPST / Tempest Therapeutics, Inc.
MDCO / Medicines Company
ADMS / Adamas Pharmaceuticals Inc
ESPR / Esperion Therapeutics, Inc.
US92220P1057 / Varian Medical Systems, Inc.
NVLN / NOVELION THERAPEUTICS INC.
CI / The Cigna Group
IART / Integra LifeSciences Holdings Corporation
PGNX / Progenics Pharmaceuticals, Inc. Call
NSTG / NanoString Technologies, Inc.
REPH / Societal CDMO Inc
LJPC / La Jolla Pharmaceutical Co.
ZGNX / Zogenix Inc
ANAB / AnaptysBio, Inc.
CORI / Corium International, Inc.
MRK / Merck & Co., Inc.
KALA / KALA BIO, Inc.
/ Oxford Immunotec Global PLC
PETX / Aratana Therapeutics, Inc.
451731103 / Ignyta, Inc.
ATEC / Alphatec Holdings, Inc.
IOVA / Iovance Biotherapeutics, Inc.
US00163U1060 / AMAG Pharmaceuticals, Inc.
SBBP / Strongbridge Biopharma plc
ADMA / ADMA Biologics, Inc.
NVTA / Invitae Corporation
TVTX / Travere Therapeutics, Inc.
RGLS / Regulus Therapeutics Inc.
SSKN / STRATA Skin Sciences, Inc.
ENDP / Endo International plc
CDTX / Cidara Therapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
CFRX / ContraFect Corp
TLGT / Teligent Inc
AVDL / Avadel Pharmaceuticals plc
CPRX / Catalyst Pharmaceuticals, Inc.
TVTX / Travere Therapeutics, Inc. Call
SCYX / SCYNEXIS, Inc.
HZNP / Horizon Therapeutics Plc
HZNP / Horizon Therapeutics Plc Call
HRTX / Heron Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
BDSI / Biodelivery Sciences International